224 related articles for article (PubMed ID: 9006785)
1. Effect of gallbladder contraction induced cholagogia on the pharmacokinetic profile of a sustained-release theophylline formulation.
Fuchs WS; von Nieciecki A; Molz KH; Popescu G; Weil A; Barkworth MF; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1996 Dec; 46(12):1120-6. PubMed ID: 9006785
[TBL] [Abstract][Full Text] [Related]
2. [The effect of bile secretion on the pharmacokinetics of a theophylline sustained-release preparation].
Fuchs WS; von Nieciecki A; Molz KH; Popescu G; Weil A; Barkworth MF; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):597-604. PubMed ID: 9676352
[TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability and bioequivalence study of theophylline sustained release formulations.
Vergin H; Mahr G; Winterhalter B; Wigand R
Arzneimittelforschung; 2003; 53(9):635-9. PubMed ID: 14558437
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
5. [The effect of food on theophylline absorption].
Pabst G; Weber W; Müller M; Barkworth MF
Arzneimittelforschung; 1998 May; 48(5A):569-73. PubMed ID: 9676346
[TBL] [Abstract][Full Text] [Related]
6. Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects.
Keller J; Trautmann ME; Haber H; Tham LS; Hunt T; Mace K; Linnebjerg H
Regul Pept; 2012 Nov; 179(1-3):77-83. PubMed ID: 22960288
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
[TBL] [Abstract][Full Text] [Related]
8. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].
von Nieciecki A; Fuchs WS; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348
[TBL] [Abstract][Full Text] [Related]
9. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
[TBL] [Abstract][Full Text] [Related]
10. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
12. Influence of food on the bioavailability of theophylline from a sustained-released theophylline preparation.
Lohmann A; Dingler E; Sommer W
Arzneimittelforschung; 1991 Jul; 41(7):732-4. PubMed ID: 1772462
[TBL] [Abstract][Full Text] [Related]
13. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
Pabst G; Weber W; Müller M; Barkworth MF
Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
[TBL] [Abstract][Full Text] [Related]
15. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
Contreras J; Pérez N; González R; Ontivero E; López M
Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
17. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of smoking on gallbladder emptying and refilling in chronic smokers and nonsmokers: a sonographic study.
Degirmenci B; Albayrak R; Haktanir A; Acar M; Yucel A
World J Gastroenterol; 2006 Sep; 12(34):5540-3. PubMed ID: 17006996
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence of immediate-release theophylline capsules.
Meyer MC; Jarvi EJ; Straughn AB; Pelsor FR; Williams RL; Shah VP
Biopharm Drug Dispos; 1999 Dec; 20(9):417-9. PubMed ID: 10951430
[TBL] [Abstract][Full Text] [Related]
20. Duodenal phytohaemagglutinin (red kidney bean lectin) stimulates gallbladder contraction in humans.
Purhonen AK; Herzig KH; Gabius HJ; André S; Ketterer S; Matzinger D; Beglinger C; Hildebrand P
Acta Physiol (Oxf); 2008 Jul; 193(3):241-7. PubMed ID: 18248661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]